At best, it is hypothesis-generating , and at worst, the findings may simply reflect placebo effects or biased reporting
A phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) reported substantial weight loss and improvements in glycaemic parameters, though the trial was conducted in a closely monitored clinical setting with defined eligibility criteria
Glucagon: Increases energy expenditure by boosting metabolism, helping to mobilise fat stores effectively
AOD-9604 also appears in cartilage repair research (originally investigated for osteoarthritis before pivoting to obesity), because the hGH fragment retains some regenerative signaling without the proliferative risks of full hGH
Votre partenaire Depuis plus de 20 ans, une quipe de professionnels votre entire disposition
By technically positioning the product as a research chemical rather than a drug intended for human use, vendors sidestep the FDA oversight that governs pharmaceutical products